Search research articles
Contact Us
Filters
Showing results (101-110 of 290) with videos related to
Page
of 29
Sort By:
Journal of Thrombosis and Thrombolysis
|
January 30, 2023
Adverse events in low versus normal body weight patients prescribed apixaban for atrial fibrillation
Deborah DeCamillo, Brian Haymart, Xiaowen Kong, et al.
The American Journal of Medicine
|
December 7, 2018
Periprocedural Antithrombotic Management from a Patient Perspective: A Qualitative Analysis
Jennifer Acosta, Christopher Graves, Elizabeth Spranger, et al.
Thrombosis Research
|
May 21, 2016
Use of decision aids for shared decision making in venous thromboembolism: A systematic review
Geoffrey D Barnes, Brett Izzo, Marisa L Conte, et al.
Arthritis Care & Research
|
December 20, 2016
A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia
Nayef M Kazzaz, Allecia M Wilson, Ruba Kado, et al.
Implementation Science Communications
|
June 29, 2023
Dynamic interplay between available resources and implementation climate across phases of implementation: a qualitative study of a VA national population health tool
Ying-Jen Lin, Allison Ranusch, F Jacob Seagull, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
September 11, 2020
Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection
Andrea T Obi, Geoffrey D Barnes, Lena M Napolitano, et al.
The American Journal of Cardiology
|
November 11, 2015
Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥ 65 Years With Nonvalvular Atrial Fibrillation
Brian M Salata, David W Hutton, Deborah A Levine, et al.
The Annals of Pharmacotherapy
|
August 14, 2018
Clinical Safety Outcomes in Patients With Nonvalvular Atrial Fibrillation on Rivaroxaban and Diltiazem
Jenna W Bartlett, Elizabeth Renner, Erin Mouland, et al.
Thrombosis and Haemostasis
|
January 8, 2025
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban
Mehrdad Zarghami, Sina Rashedi, Gregory Piazza, et al.
Journal of General Internal Medicine
|
October 31, 2025
Untreated Atrial Fibrillation: Public Health Threat or Data Blind Spot?
Zainab Mian, Morris Fabbri, Jay Patel, et al.
Page
of 29
Search research articles
Search
Showing results (101-110 of 290) with videos related to
Sort By:
Page
of 29
Journal of Thrombosis and Thrombolysis
|
January 30, 2023
Adverse events in low versus normal body weight patients prescribed apixaban for atrial fibrillation
Deborah DeCamillo, Brian Haymart, Xiaowen Kong, et al.
The American Journal of Medicine
|
December 7, 2018
Periprocedural Antithrombotic Management from a Patient Perspective: A Qualitative Analysis
Jennifer Acosta, Christopher Graves, Elizabeth Spranger, et al.
Thrombosis Research
|
May 21, 2016
Use of decision aids for shared decision making in venous thromboembolism: A systematic review
Geoffrey D Barnes, Brett Izzo, Marisa L Conte, et al.
Arthritis Care & Research
|
December 20, 2016
A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia
Nayef M Kazzaz, Allecia M Wilson, Ruba Kado, et al.
Implementation Science Communications
|
June 29, 2023
Dynamic interplay between available resources and implementation climate across phases of implementation: a qualitative study of a VA national population health tool
Ying-Jen Lin, Allison Ranusch, F Jacob Seagull, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
September 11, 2020
Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection
Andrea T Obi, Geoffrey D Barnes, Lena M Napolitano, et al.
The American Journal of Cardiology
|
November 11, 2015
Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥ 65 Years With Nonvalvular Atrial Fibrillation
Brian M Salata, David W Hutton, Deborah A Levine, et al.
The Annals of Pharmacotherapy
|
August 14, 2018
Clinical Safety Outcomes in Patients With Nonvalvular Atrial Fibrillation on Rivaroxaban and Diltiazem
Jenna W Bartlett, Elizabeth Renner, Erin Mouland, et al.
Thrombosis and Haemostasis
|
January 8, 2025
Heterogeneity in American and European Peripheral Artery Disease Guidelines on Non-statin Lipid-Lowering Therapy and Rivaroxaban
Mehrdad Zarghami, Sina Rashedi, Gregory Piazza, et al.
Journal of General Internal Medicine
|
October 31, 2025
Untreated Atrial Fibrillation: Public Health Threat or Data Blind Spot?
Zainab Mian, Morris Fabbri, Jay Patel, et al.
Page
of 29